Buy Tiotropium Bromide
Tiotropium Bromide

38.25
A long-acting bronchodilator used daily to help keep the airways open in people with chronic lung conditions.


Ingredient
Availability
In Stock
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Product Sheet

Alternative/Local Brand
Spiriva
Active Ingredient(s)
Tiotropium
Primary Category
Asthma & COPD
Therapeutic Class
Respiratory, Bronchodilators, Anticholinergics
Pharmacological Class
Long-acting muscarinic antagonist (LAMA)
Indications
Chronic obstructive pulmonary disease (COPD), Maintenance treatment of asthma
Contraindications
Hypersensitivity to atropine, Allergy to milk protein (for some powder inhalers)
Minor Side Effects
Dry mouth, Sore throat, Cough
Moderate Side Effects
Nasal irritation, Constipation, Dizziness, Heartburn
Serious Side Effects
Sudden breathing difficulty (bronchospasm), Blurred vision or eye pain, Irregular heartbeat, Difficulty passing urine
Dosage Forms
Inhalation powder (capsule for inhaler), Inhalation solution
Administration Route
Inhalation
Mechanism of Action
It works by blocking muscarinic receptors in the lungs, which helps to relax and open the airways. This makes breathing easier and prevents flare-ups of COPD or asthma.
Prescription Status
Rx
Patient Summary
A long-acting bronchodilator used daily to help keep the airways open in people with chronic lung conditions.
Onset Time
30 minutes (not for acute relief)
Duration
24 hours
Storage Instructions
Store inhaler and capsules at room temperature; do not freeze.
Drug Interactions
Ipratropium, Other anticholinergic drugs
Age Restrictions
Approved for adults and children (asthma age limits vary by product)
Pregnancy Use
Consult a doctor; use during pregnancy only if benefit outweighs risk.
Alternative Drugs
Ipratropium, Umeclidinium, Aclidinium

Tiotropium Bromide: What Is It?

Tiotropium bromide is a prescription medication used to improve breathing in people with chronic obstructive pulmonary disease (COPD) and asthma. It belongs to the respiratory health class of drugs and works by relaxing the muscles around the airways. The medication is supplied as a 9 mcg inhaler, designed for once-daily use. In Hong Kong, the Drug Office of the Department of Health oversees its approval and availability.

How Tiotropium Bromide Works in the Body

Tiotropium is a long-acting anticholinergic (also called a long-acting muscarinic antagonist, LAMA). It blocks the action of acetylcholine on muscarinic M₃ receptors located on airway smooth muscle. By preventing this signal, the airway muscles stay relaxed, allowing more air to flow in and out of the lungs.

Key pharmacologic points:

  • Onset of action: within 30 minutes after inhalation.
  • Peak effect: 3-4 hours.
  • Duration: up to 24 hours, supporting once-daily dosing.
  • Bioavailability: negligible systemic absorption because the drug is primarily deposited in the lungs.
  • Metabolism: minimal hepatic metabolism; the small amount absorbed is excreted unchanged in urine and feces.

Treating Respiratory Conditions with Tiotropium Bromide

Approved Indications

In Hong Kong, tiotropium bromide is approved for:

  • Maintenance treatment of COPD (including chronic bronchitis and emphysema).
  • Maintenance therapy for asthma in patients who remain symptomatic despite inhaled corticosteroids.

These indications align with approvals from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Tiotropium is not intended for acute bronchospasm relief; a short-acting bronchodilator should be used for sudden symptoms.

Typical Patient Populations

  • Adults with a confirmed diagnosis of COPD who experience frequent exacerbations or breathlessness.
  • Adults with persistent asthma whose symptoms are not fully controlled on inhaled corticosteroids alone.

Tiotropium is not recommended for children under 6 years of age, and safety in younger children has not been established.

Patient Suitability and Contraindications

Absolute Contraindications

  • Known hypersensitivity to tiotropium or any component of the inhaler.
  • History of acute narrow-angle glaucoma or severe urinary retention (e.g., due to prostatic hypertrophy) where anticholinergic effects could worsen the condition.

Relative Contraindications

  • Moderate to severe renal impairment (creatinine clearance < 30 mL/min).
  • Pregnancy or breastfeeding: limited human data; use only if the potential benefit justifies the risk.
  • Elderly patients: may be more sensitive to anticholinergic side effects such as dry mouth.

Special Populations

  • Pregnancy: Category B (animal studies show no risk, but no adequate human studies).
  • Lactation: Small amounts may be excreted in breast milk; consider the infant’s condition when deciding to continue therapy.

Safety Profile: Side Effects and Interactions

Common Side Effects

  • Dry mouth
  • Constipation
  • Cough or throat irritation after inhalation
  • Nasal dryness

These effects are usually mild and improve with continued use or by taking the inhaler after drinking water.

Serious Adverse Events

  • Paradoxical bronchospasm: sudden worsening of breathing; seek emergency care.
  • Allergic reactions: rash, swelling, or difficulty breathing; discontinue and obtain medical attention.
  • Urinary retention or worsening of glaucoma symptoms in susceptible individuals.

Drug Interactions

  • Major: Co-administration with other anticholinergic agents (e.g., certain antihistamines) may increase anticholinergic load; monitor for worsening dry mouth, constipation, or urinary issues.
  • Moderate: Concurrent use of strong CYP3A4 inhibitors (e.g., itraconazole) has minimal effect because tiotropium undergoes minimal hepatic metabolism, but clinicians may still review the full medication list.
  • Caution: Beta-agonists, corticosteroids, and other COPD/asthma inhalers are commonly used together and do not have known pharmacokinetic conflicts.

Food and Lifestyle Interactions

  • No specific food restrictions.
  • Alcohol does not significantly alter tiotropium’s effect but may increase the risk of dizziness in some patients.
  • Operating machinery: tiotropium does not impair cognition, yet patients experiencing severe breathlessness should avoid hazardous activities until stabilized.

Dosing and Administration Guidelines

  • Standard dose: One inhalation (9 mcg) once daily, preferably at the same time each day.
  • Device: Tiotropium Respimat inhaler. Prime the inhaler according to the manufacturer’s instructions before first use and after a period of non-use.
  • Inhalation technique:
  • Exhale fully away from the device.
  • Place the mouthpiece in your mouth, close lips around it, and inhale slowly and deeply.
  • Hold your breath for about 10 seconds, then exhale normally.

Special Populations

  • Renal impairment: No dose adjustment needed for mild to moderate impairment; severe impairment warrants clinical judgment.
  • Elderly: Use the same dose; monitor for anticholinergic side effects.

Missed Dose

If a dose is missed, take it as soon as you remember unless it is close to the time of the next scheduled dose. Do not double the dose.

Overdose

Symptoms may include severe dry mouth, constipation, urinary retention, or paradoxical bronchospasm. Seek immediate medical attention; treatment is supportive, focusing on airway management and symptom relief.

Discontinuation

Tiotropium does not require tapering. Discontinue under medical guidance if adverse effects become intolerable or if a change in therapy is needed.

Monitoring and Follow-Up

  • Pulmonary function tests (spirometry) at baseline and periodically (e.g., every 3-6 months) to assess response.
  • Symptom diary: record daily breathlessness scores, rescue inhaler use, and any side effects.
  • Renal function: evaluate in patients with known kidney disease annually.
  • Eye pressure: in patients with glaucoma, monitor intraocular pressure as recommended by an ophthalmologist.

Storage and Handling

  • Store the inhaler at room temperature (15-30 °C).
  • Keep the device away from direct sunlight and moisture.
  • Do not refrigerate.
  • Replace the inhaler cartridge when the indicator shows “low dose” or after 30 days of continuous use, whichever comes first.
  • Keep out of reach of children; use child-proof caps if available.

Medication-Specific Glossary

Anticholinergic
A drug that blocks the action of acetylcholine on muscarinic receptors, leading to relaxation of smooth muscle in the airways.
Bronchodilator
An agent that widens the bronchial passages, improving airflow and reducing resistance in the lungs.
Respimat inhaler
A soft-mist inhalation device that generates a fine aerosol for deep lung deposition, used for delivering tiotropium bromide.
Inhalation technique
The coordinated steps a patient follows to ensure the medication reaches the lower airways efficiently.

Medical Disclaimer

This article provides educational information about tiotropium bromide and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.

Tiotropium Bromide FAQ

Can I use tiotropium bromide with my rescue inhaler?

Yes. Tiotropium is a maintenance medication and does not replace short-acting bronchodilators (e.g., albuterol). Use your rescue inhaler as directed for sudden breathlessness; tiotropium should be taken once daily regardless of rescue use.

What should I do if I accidentally inhale more than one puff?

Do not take an additional dose to “make up” for the extra puff. If you experience symptoms such as severe dry mouth, urinary difficulty, or worsening breathing, contact a healthcare professional promptly.

Is there a difference between the 9 mcg inhaler and other strengths?

The 9 mcg Respimat inhaler is the standard once-daily dose approved for COPD and asthma maintenance. Higher strengths (e.g., 18 mcg) exist for specific regions but are not part of the usual regimen in Hong Kong.

Can tiotropium bromide affect my blood pressure?

Tiotropium’s anticholinergic action can cause a mild increase in heart rate but usually does not significantly raise blood pressure. Patients with uncontrolled hypertension should discuss any concerns with their clinician.

How long before I see improvement after starting tiotropium?

Patients often notice reduced breathlessness and fewer exacerbations within a few weeks, although maximal benefit may take up to several months of consistent use.

Are there any dietary restrictions while using this inhaler?

No specific foods need to be avoided. Maintaining adequate hydration can help mitigate dry-mouth sensations that sometimes accompany tiotropium use.

What is the environmental impact of disposing of the inhaler?

The inhaler contains plastic components and a metal cartridge. Follow local waste-segregation guidelines: empty cartridges should be returned to pharmacy take-back programs when available, and the outer plastic can be recycled.

Can I travel internationally with my tiotropium inhaler?

Yes. Carry the inhaler in your hand luggage, keep the original labeling, and have a copy of your prescription or a doctor’s note if required by customs or airline security.

Is tiotropium safe for patients with heart disease?

Clinical studies have not shown a clinically significant increase in cardiovascular events in patients with stable heart disease. Nonetheless, patients with recent cardiac events should consult their cardiologist before initiating therapy.

What should I do if I lose my inhaler while away from home?

Contact a local pharmacy or urgent care center for a short-term supply. Provide your prescription details and indicate that you need a replacement for tiotropium bromide 9 mcg inhaler.

Categories